Anheuser-Busch InBev (NYSE:BUD) delivered a 6% gain this week, outpacing both the S&P 500 and its consumer staples peers. The world’s largest brewer is trading at $80.39, approaching its 52-week high of $81.56. Three distinct storylines drove the move, each revealing where this company stands heading into 2026.
The Stock’s Week: Outperformance Across Every Timeframe
BUD’s 6% weekly gain more than tripled the Consumer Staples sector ETF’s 1.8% rise. Year-to-date, BUD is up 25.5% versus 15.2% for consumer staples broadly. Over the past year, the stock has surged 54%, crushing the sector’s 13% return.
Even competitor Molson Coors (NYSE:TAP), which gained 2.8% this week, couldn’t keep pace. BUD is capturing momentum that extends beyond simple sector rotation.
Storyline 1: Analyst Price Targets Surge Past $100
Wall Street dramatically repriced BUD’s upside this week. Evercore ISI raised its price target from $75 to $100 on February 13, maintaining an Outperform rating. That’s a 33% increase and implies 24% upside from current levels.
Wells Fargo followed with two separate increases, first moving from $75 to $85 on February 9, then raising again to $88 days later. Goldman Sachs, Barclays, and JPMorgan all reaffirmed Buy ratings with price targets clustering between $77 and $94.
BUD now carries a $79.10 average analyst target with 9 Buy or Strong Buy ratings versus just 3 Holds and zero Sells. When multiple firms raise targets simultaneously, it signals something fundamental changed in their models.
Storyline 2: Q4 Earnings Beat Extends Four-Quarter Streak
The catalyst arrived Thursday morning when Anheuser-Busch Inbev reported Q4 EPS of $0.95, beating the $0.89 consensus by 7%. Revenue came in at $15.55 billion with organic revenue growth of 2.5% and EBITDA growth of 4.9%.
This marks the fourth consecutive quarter BUD exceeded estimates. The company generated $11.3 billion in free cash flow last year while expanding margins by 101 basis points. Management guided to 4% to 8% EBITDA growth for 2026, suggesting confidence despite volume headwinds in China and Brazil.
The premiumization strategy is working. Higher-margin brands are offsetting volume declines, a playbook that matters more than unit sales when margins expand triple digits year-over-year.
Storyline 3: Valuation Concerns Emerge Despite Momentum
Anheuser-Busch Inbev trades at 27x trailing earnings, elevated for a beverage company facing volume pressures. GuruFocus flagged the stock as potentially overvalued despite strong earnings momentum.
Short interest tells a mixed story. Only 0.9% of the float is sold short, well below the 7.8% peer average, but that short interest increased 7% recently. Some institutional players trimmed positions in Q3, including Envestnet, which reduced its stake by 10.7%.
The bull case hinges on whether premium brand momentum and margin expansion justify the multiple. The bear case points to volume declines and geographic weakness that could pressure growth if consumer spending softens. At current levels, BUD is priced for execution, not forgiveness.
Top Gaining Stocks
Top Losing Stocks